BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 5081589)

  • 1. Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1972 Aug; 56(4):465-72. PubMed ID: 5081589
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.
    Housholder GE; Loo TL
    J Pharmacol Exp Ther; 1971 Nov; 179(2):386-95. PubMed ID: 5133607
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
    Carter SK; Friedman MA
    Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells in culture.
    Gerulath AH; Loo TL
    Biochem Pharmacol; 1972 Sep; 21(17):2335-43. PubMed ID: 4675028
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of chelating agents upon the synthesis of nucleic acids and protein: inhibition of DNA synthesis by 1-formylisoquinoline thiosemicarbazone.
    Sartorelli AC
    Biochem Biophys Res Commun; 1967 Apr; 27(1):26-32. PubMed ID: 6048237
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).
    Allen LM; Creaven PJ
    Cancer Res; 1973 Dec; 33(12):3112-6. PubMed ID: 4796799
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic effects of some tumor-inhibitory pyridine carboxaldehyde thiosemicarbazones.
    Booth BA; Moore EC; Sartorelli AC
    Cancer Res; 1971 Mar; 31(3):228-34. PubMed ID: 5547210
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the mechanism of cytostatic action of methylhydrazine, II].
    Weitzel G; Schneider F; Fretzdorff AM; Durst J; Hirschmann WD
    Hoppe Seylers Z Physiol Chem; 1967 Apr; 348(4):433-42. PubMed ID: 5587962
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical effects of the Vinca alkaloids. IV. Studies with vinleurosine.
    Creasey WA
    Biochem Pharmacol; 1969 Jan; 18(1):227-32. PubMed ID: 5780988
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticancer effects of propanals: comparison between human and animal tumor systems.
    Apple MA; Cline MJ
    Natl Cancer Inst Monogr; 1971 Dec; 34():161-5. PubMed ID: 5140861
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanism of action of the epidermal growth factor. 3. Stimulation of the uptake of labeled precursors into RNA, DNA and proteins induced by EGF in isolated tumor cells.
    Covelli I; Mozzi R; Rossi R; Frati L
    Hormones; 1972; 3(3):183-91. PubMed ID: 4676050
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effects of the antitumor agents 5-(Dimethyltriazeno)-imidazole-4-carboxamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on cell cycle of L1210 leukemia cells in vivo.
    Shirakawa S; Frei E
    Cancer Res; 1970 Aug; 30(8):2173-90. PubMed ID: 5459764
    [No Abstract]   [Full Text] [Related]  

  • 13. Microsomal metabolism of triazenylimidazoles.
    Hill DL
    Cancer Res; 1975 Nov; 35(11 Pt 1):3106-10. PubMed ID: 241485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea derivatives: oxamyl hydroxamic acid.
    Gale GR
    Cancer Res; 1966 Nov; 26(11):2340-8. PubMed ID: 5334143
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on camptothecin. I. Effects of nucleic acid and protein synthesis.
    Horwitz SB; Chang CK; Grollman AP
    Mol Pharmacol; 1971 Nov; 7(6):632-44. PubMed ID: 4948241
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.
    Beal DD; Skibba JL; Whitnable KK; Bryan GT
    Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic behavior of tumor slices under the influence of cytostatic compounds].
    Athen B; Guglielmi H
    Hoppe Seylers Z Physiol Chem; 1969 Jul; 350(7):803-8. PubMed ID: 5806554
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man.
    Skibba JL; Ramirez G; Beal DD; Bryan GT
    Biochem Pharmacol; 1970 Jun; 19(6):2043-51. PubMed ID: 5513972
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytostatically active N-acyloxymethyl compounds].
    Schneider F; Keup U; Seeber S
    Hoppe Seylers Z Physiol Chem; 1969 May; 350(5):635-40. PubMed ID: 5789878
    [No Abstract]   [Full Text] [Related]  

  • 20. [Utilization of pyrimidine precursors in the tumor and liver of mice with Ehrlich ascites carcinoma].
    Fedorov NA; Matveenko VN; Tikhonova EF
    Biull Eksp Biol Med; 1970 Dec; 70(12):66-9. PubMed ID: 5503816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.